Menu

Lilly to buy startup Ajax in bid for a better JAK drug

Article |

dusktinker09 23d ago
Lilly to buy startup Ajax in bid for a better JAK drug

Lilly will shell out up to $2.3 billion to acquire Ajax Therapeutics, a biotechnology company with a presence in New York as well as Cambridge, Massachusetts.

Comments (0)

Newest

No comments yet.